Casa
kurnik login

Factor VIII inhibitors in hemophilia A treated with emicizumab

Por um escritor misterioso

Descrição
Factor VIII inhibitors in hemophilia A treated with emicizumab
JCM, Free Full-Text
Factor VIII inhibitors in hemophilia A treated with emicizumab
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
Factor VIII inhibitors in hemophilia A treated with emicizumab
Characterizing Emicizumab with Immune Tolerance Induction Therapy
Factor VIII inhibitors in hemophilia A treated with emicizumab
Substitution therapy – Canadian Hemophilia Society
Factor VIII inhibitors in hemophilia A treated with emicizumab
Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis
Factor VIII inhibitors in hemophilia A treated with emicizumab
Frontiers Tolerating Factor VIII: Recent Progress
Factor VIII inhibitors in hemophilia A treated with emicizumab
Hemlibra® (emicizumab-kxwh) for the Treatment of Haemophilia A
Factor VIII inhibitors in hemophilia A treated with emicizumab
National Hemophilia Foundation (NHF) - Posters - Characteristics
Factor VIII inhibitors in hemophilia A treated with emicizumab
Inhibitors in Hemophilia: A New Approach in Prevention & Treatment
Factor VIII inhibitors in hemophilia A treated with emicizumab
A new standard of care in hemophilia A?
Factor VIII inhibitors in hemophilia A treated with emicizumab
Advances and innovations in haemophilia treatment
Factor VIII inhibitors in hemophilia A treated with emicizumab
Determining the Approximate Factor VIII Level Equivalency of
Factor VIII inhibitors in hemophilia A treated with emicizumab
Hemophilia Treatment Market Share Outlook 2022-2028
Factor VIII inhibitors in hemophilia A treated with emicizumab
Frontiers Escape or Fight: Inhibitors in Hemophilia A
Factor VIII inhibitors in hemophilia A treated with emicizumab
Pharmacoeconomic Report: Emicizumab (Hemlibra) - NCBI Bookshelf
de por adulto (o preço varia de acordo com o tamanho do grupo)